Caisse DE Depot ET Placement DU Quebec cut its stake in shares of Clorox Company (The) (NYSE:CLX) by 53.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,805 shares of the company’s stock after selling 14,700 shares during the period. Caisse DE Depot ET Placement DU Quebec’s holdings in Clorox Company (The) were worth $1,728,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares during the last quarter. Parnassus Investments CA acquired a new position in shares of Clorox Company (The) during the first quarter worth about $434,255,000. Geode Capital Management LLC increased its stake in shares of Clorox Company (The) by 4.3% in the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock worth $168,019,000 after buying an additional 51,563 shares during the period. Ameriprise Financial Inc. increased its stake in shares of Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock worth $146,932,000 after buying an additional 25,110 shares during the period. Finally, Swiss National Bank increased its stake in shares of Clorox Company (The) by 13.8% in the first quarter. Swiss National Bank now owns 915,092 shares of the company’s stock worth $123,382,000 after buying an additional 110,700 shares during the period. 70.29% of the stock is currently owned by institutional investors and hedge funds.

Shares of Clorox Company (CLX) traded up 0.75% during midday trading on Monday, hitting $135.50. The stock had a trading volume of 584,768 shares. The firm’s 50-day moving average price is $134.79 and its 200-day moving average price is $133.07. Clorox Company has a one year low of $111.24 and a one year high of $141.76. The firm has a market capitalization of $17.45 billion, a PE ratio of 26.77 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business’s revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.30 EPS. On average, equities analysts predict that Clorox Company will post $5.68 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This report was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/08/07/caisse-de-depot-et-placement-du-quebec-has-1-73-million-stake-in-clorox-company-the-nyseclx-updated-updated-updated.html.

A number of equities research analysts have recently weighed in on the company. Barclays PLC lowered their price target on Clorox Company (The) from $140.00 to $136.00 and set an “equal weight” rating for the company in a report on Friday. BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the company a “buy” rating in a report on Thursday. Royal Bank Of Canada restated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. BidaskClub upgraded Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. Finally, Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $129.13.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.